In a remarkable achievement highlighting its commitment to innovation and excellence, SHL Technologies has distinguished itself among Sartorius AG’s suppliers and won the ‘Supplier Award’.
SHL Technologies will be exhibiting at 4F Booth #N1206 on Aug 23 – 26.
SHL Technologies, a subsidiary of SHL Medical, is pleased to announce that InsulCheck® DOSE by Innovation Zed has secured CE mark.
InsulCheck CONNECT, manufactured by SHL Technologies, wins the 2021 Good Design Award
Our manufacturing, supply, and office work maintain regular operations under the precautionary measures we have implemented to help reduce human contact. We are constantly tracking the government’s policies concerning COVID developments, so as to adapt and make adjustments to our manpower allocation or shift schedules.
On November 5, SHL Group, a global leader in the design, development, and manufacturing of drug delivery devices, held the inauguration of its new Liufu site in Taoyuan City, Taiwan.
On January 28, Innovation Zed Ltd. entered into a commercial partnership with diagnostics company A. Menarini Diagnostics to market the insulin pen “InsulCheck Connect” add-on device.
On November 5, SHL Group, a global leader in the design, development, and manufacturing of drug delivery devices, held the inauguration of its new Liufu site in Taoyuan City, Taiwan.
